Cleared Traditional

K052004 - VASCON NEUROPATH GUIDING CATHETER

K052004 is an FDA 510(k) clearance for VASCON NEUROPATH GUIDING CATHETER, manufactured by Vascon, LLC. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 178-day FDA review.

K052004 · Vascon, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
178d
Days
Class 2
Risk

K052004 is an FDA 510(k) clearance for the VASCON NEUROPATH GUIDING CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vascon, LLC (Coral Springs, US). The FDA issued a Cleared decision on January 19, 2006 after a review of 178 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vascon, LLC devices

FDA 510(k) Submission Details - K052004

510(k) Number K052004 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2005
Decision Date January 19, 2006
Days to Decision 178 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 125d · This submission: 178d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 672
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K052004.
MODIFICATION TO POLARCATH PERIPHERAL DILATATION SYSTEM
K060572 · Boston Scientific Corporation · Mar 2006
CPS AIM INNER CATHETER, MODELS 410140, 410141, 410142, 410144, 410145, 410146, 410147, 410148
K053217 · St Jude Medical · Mar 2006
CPS DIRECT SL OUTER CATHETER
K053277 · St Jude Medical · Feb 2006
STERLING OTW PTA BALLOON DILATATION CATHETER, MODEL H74939032-XXXXXX
K053116 · Boston Scientific Corp · Dec 2005
STERLING MONORAIL PTA BALLOON DILATATION CATHETER, MODEL H74939031-XXXXXX
K053118 · Boston Scientific Corp · Dec 2005
VASCULAR SOLUTIONS SKYWAY SUPPORT CATHETER
K052258 · Vascular Solutions, Inc. · Dec 2005